glucagon-like peptide 2-(2-33)



glucagon-like peptide 2-(2-33)

A1AA1D2DD2G3GG3S4SS4F5FF5S6SS6D7DD7E8EE8M9MM9N10NN10T11TT11I12II12L13LL13D14DD14N15NN15L16LL16A17AA17T18TT18R19RR19D20DD20F21FF21I22II22N23NN23W24WW24L25LL25I26II26Q27QQ27T28TT28K29KK29I30II30T31TT31D32DD32

SMILES None
InChIKey OQGQYLSDVZWIPO-QSSAVJFTSA-N
Sequence ADGSFSDEMNTILDNLATRDFINWLIQTKITD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

glucagon-like peptide 2-(2-33)

A1AA1D2DD2G3GG3S4SS4F5FF5S6SS6D7DD7E8EE8M9MM9N10NN10T11TT11I12II12L13LL13D14DD14N15NN15L16LL16A17AA17T18TT18R19RR19D20DD20F21FF21I22II22N23NN23W24WW24L25LL25I26II26Q27QQ27T28TT28K29KK29I30II30T31TT31D32DD32

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.